Evidence map›Paper›PMID 36481983›Full record

ArticlePhotochemistry and photobiology2023

Establishing a Robust and Reliable Response from a Potent Osmium-Based Photosensitizer Via Lipid Nanoformulation

Houston D Cole, Menitte Eroy, John A Roque, Ge Shi, Mina Guirguis, John Fakhry, Colin G Cameron, Girgis Obaid, Sherri A McFarland

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Photochemistry and photobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Houston D ColeDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX.
Menitte EroyDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX.
John A RoqueDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX.
Ge ShiDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX.
Mina GuirguisDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX.
John FakhryDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX.
Colin G CameronDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX.ORCID 0000-0003-0978-0894
Girgis ObaidDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX.ORCID 0000-0002-9452-4467
Sherri A McFarlandDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX.ORCID 0000-0002-8028-5055
The University of Texas at Arlington · USThe University of Texas at Dallas · US

Funding

Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapyR01CA222227 · NCI · UNIVERSITY OF TEXAS ARLINGTON · PI GUJAR, SHASHI, MCFARLAND, SHERRI · 2018 to 2022
$2.6M
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platformsR00CA215301 · NCI · UNIVERSITY OF TEXAS DALLAS · PI OBAID, GIRGIS · 2020 to 2022
$721k
NCI NIH HHS R00 CA215301NCI NIH HHS R01 CA222227NIH HHS R01CA222227
6 · The paper itself

Abstract

Osmium (Os) based photosensitizers (PSs) are a unique class of nontetrapyrrolic metal-containing PSs that absorb red light. We recently reported a highly potent Os(II) PS, rac-[Os(phen)

Indexed as

PhotochemotherapyPhotosensitizing AgentsLightLipidsLiposomesOsmiumLipidsLiposomesOsmiumPhotosensitizing Agents

Identifiers

PMID36481983
PMCPMC10315168
OpenAlexW4310951551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.